SCHEMBL25263374

SCHEMBL25263374

O=C(Nc1ccc2c(-c3ccc4c(c3)C3(CCNCC3)CC4=O)c[nH]c2n1)c1ccncc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPKAPK2 P49137 8/20 0.42
▸ DYRK1A Q13627 3/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ MELK Q14680 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ STK17A Q9UEE5 1/20 0.36
▸ DYRK1B Q9Y463 1/20 0.36
▸ HTR1A P08908 1/20 0.35
▸ HTR1D P28221 1/20 0.35
▸ HTR1B P28222 1/20 0.35
▸ HTR1F P30939 1/20 0.35
▸ P2RY14 Q15391 1/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ AAK1 Q2M2I8 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30398369 1.00 MAPKAPK2 (0.42) MAPKAPK2DYRK1ACDC7MAP4K4CDK8
SCHEMBL26176177 0.89 HTR1A (0.42) MAPKAPK2DYRK1ACDC7MAP4K4CDK8
SCHEMBL30399856 0.89 HTR1A (0.42) MAPKAPK2DYRK1ACDC7MAP4K4CDK8
SCHEMBL30400429 0.85 JAK1 (0.39) DYRK1ACDC7MAP4K4CDK8MELK
SCHEMBL26176386 0.85 JAK1 (0.39) DYRK1ACDC7MAP4K4CDK8MELK
SCHEMBL26176179 0.84 HDAC3 (0.43) MAPKAPK2DYRK1ACDC7MAP4K4CDK8
SCHEMBL30398345 0.80 JAK1 (0.42) DYRK1AHTR1AHTR1DHTR1BHTR1F
SCHEMBL26176117 0.80 JAK1 (0.42) DYRK1AHTR1AHTR1DHTR1BHTR1F
SCHEMBL26175763 0.79 CAMKK2 (0.44) DYRK1ACLK4DYRK1BGSK3BCLK1
SCHEMBL26175724 0.79 PIM1 (0.36) MAPKAPK2DYRK1ACDC7MAP4K4MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF TENARX, INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192686-A1 1H-PYRROLO[2,3-B]PYRIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 MAPKAPK2 146/4885DYRK1A 1/4885CDC7 688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback